Data / Drug companies / Vitamin B12
Vitamin B12 drugs: 4 drugs from 49 companies in the FDA NDC directory
Vitamin B12 is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 160 products in this class from 49 companies, covering 4 drugs by generic name. The main marketing category is other unapproved drugs, and the newest product started marketing on October 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 49Companies
- 160Products
- 4Drugs by generic name
Drugs in the Vitamin B12 class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Sodium fluoride | 3 | 124 |
| Folic acid | 7 | 34 |
| Cyanocobalamin | 55 | 25 |
| Tricon | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| PureTek Corporation | 28 | tablet; tablet, chewable | Other unapproved drugs | August 21, 2026 |
| Avion Pharmaceuticals, LLC | 10 | capsule, gelatin coated; tablet, coated | Other unapproved drugs | December 16, 2024 |
| Oncora Pharma, LLC | 10 | tablet | Other unapproved drugs | October 22, 2026 |
| Bryant Ranch Prepack | 7 | tablet, chewable; tablet | Other unapproved drugs | October 1, 2018 |
| Meitheal Pharmaceuticals Inc. | 6 | injection | Generic drugs (ANDA) | November 15, 2024 |
| Method Pharmaceuticals, LLC | 6 | tablet, chewable; liquid | Other unapproved drugs | October 1, 2018 |
| Acella Pharmaceuticals, LLC | 4 | capsule, gelatin coated; capsule, coated | Other unapproved drugs | August 19, 2010 |
| Bryant Ranch Prepack | 4 | tablet, chewable; tablet | Other unapproved drugs | October 1, 2018 |
| Carwin Pharmaceutical Associates, LLC | 4 | tablet, chewable; capsule, liquid filled | Other unapproved drugs | June 1, 2015 |
| Exeltis USA, Inc. | 4 | capsule, liquid filled; capsule, gelatin coated | Other unapproved drugs | March 15, 2020 |
| HF Acquisition Co LLC, DBA HealthFirst | 4 | injection, solution; injection | Generic drugs (ANDA) | January 29, 2020 |
| American Regent, Inc. | 3 | injection, solution | Generic drugs (ANDA) | May 29, 2003 |
| Asclemed USA, Inc. | 3 | injection; injection, solution | Generic drugs (ANDA) | August 3, 2022 |
| BonGeo Pharmaceuticals, Inc. | 3 | tablet, chewable | Other unapproved drugs | September 10, 2015 |
| Florrax Pharmaceutical | 3 | tablet | Other unapproved drugs | April 28, 2026 |
| Gland Pharma Limited | 3 | injection | Generic drugs (ANDA) | October 14, 2022 |
| Hikma Pharmaceuticals USA Inc. | 3 | injection | Generic drugs (ANDA) | October 20, 1971 |
| Lifestar Pharma LLC | 3 | injection, solution | Generic drugs (ANDA) | May 1, 2026 |
| Plano Pharmaceuticals Inc. | 3 | injection | Generic drugs (ANDA) | October 14, 2022 |
| Seton Pharmaceuticals | 3 | tablet, chewable; capsule, gelatin coated | Other unapproved drugs | October 1, 2009 |
| Somerset Therapeutics, LLC | 3 | injection; injection, solution | Generic drugs (ANDA) | December 18, 2018 |
| Vitruvias Therapeutics | 3 | injection, solution | Generic drugs (ANDA) | February 12, 2020 |
| Winder Laboratories LLC | 3 | tablet, chewable | Other unapproved drugs | December 1, 2023 |
| Zydus Lifesciences Limited | 3 | injection, solution | Generic drugs (ANDA) | May 5, 2022 |
| Zydus Pharmaceuticals USA Inc. | 3 | injection, solution | Generic drugs (ANDA) | May 5, 2022 |
| A-S Medication Solutions | 2 | tablet; injection, solution | Other unapproved drugs | January 2, 2019 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | Generic drugs (ANDA) | October 18, 2000 |
| Henry Schein, Inc. | 2 | injection, solution | Generic drugs (ANDA) | May 8, 2025 |
| Professional Complementary Health Formulas | 2 | liquid | Unapproved homeopathic products | August 15, 1984 |
| Remedyrepack Inc. | 2 | tablet | Other unapproved drugs | January 20, 2025 |
| U.S. Pharmaceutical Corporation | 2 | capsule; capsule, liquid filled | Other unapproved drugs | June 24, 2009 |
| Womens Choice Pharmaceuticals LLC | 2 | tablet, film coated; capsule, gelatin coated | Other unapproved drugs | July 20, 2017 |
| BioActive Nutritional, Inc. | 1 | liquid | Unapproved homeopathic products | June 15, 2021 |
| BluePoint Laboratories | 1 | injection, solution | Generic drugs (ANDA) | April 7, 2025 |
| Dna Labs, Inc. | 1 | solution | Unapproved homeopathic products | January 1, 1990 |
| Eugia US LLC | 1 | injection, solution | Generic drugs (ANDA) | December 8, 2020 |
| Lupin Pharmaceuticals,Inc. | 1 | spray, metered | Generic drugs (ANDA) | January 29, 2024 |
| Mission Pharmacal Company | 1 | tablet, film coated | Other unapproved drugs | February 4, 2010 |
| Nnodum Pharmaceuticals | 1 | capsule | Other unapproved drugs | May 20, 2005 |
| NorthStar RxLLC | 1 | injection, solution | Generic drugs (ANDA) | September 1, 2024 |
| Padagis Israel Pharmaceuticals Ltd | 1 | spray | Generic drugs (ANDA) | December 28, 2023 |
| Par Health USA, LLC | 1 | spray | New drug applications (NDA) | August 13, 2009 |
| Patrin Pharma, Inc. | 1 | tablet | Other unapproved drugs | April 1, 2013 |
| ProBLEN | 1 | spray | Unapproved homeopathic products | November 1, 2019 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | March 15, 2023 |
| Skya Health, LLC | 1 | capsule, gelatin coated | Other unapproved drugs | September 4, 2026 |
| Sola Pharmaceuticals, LLC | 1 | injection | Generic drugs (ANDA) | August 3, 2022 |
| Sportpharm LLC | 1 | injection | Generic drugs (ANDA) | December 11, 2015 |
| Xseer Pharmaceuticals | 1 | injection | Other unapproved drugs | June 1, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 45 | 28.1% |
| Injection, solution | 29 | 18.1% |
| Tablet, chewable | 27 | 16.9% |
| Injection | 23 | 14.4% |
| Capsule, gelatin coated | 11 | 6.9% |
| Capsule | 5 | 3.1% |
| Liquid | 5 | 3.1% |
| Tablet, film coated | 4 | 2.5% |
| Capsule, liquid filled | 4 | 2.5% |
| Spray | 3 | 1.9% |
| Spray, metered | 1 | 0.6% |
| Solution | 1 | 0.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.